Bloomberg reported on July 20, 2026 that cryptocurrency has become the default way to pay for research peptides online. The shift is not ideological — it is what remains after two years of banks and card networks cutting peptide sellers off from ordinary card processing.
For anyone comparing vendors, that changes the checkout, not the product. Below is why the payment rail moved, which sellers take crypto, where a crypto discount actually exists, and how a transaction clears.
Research-context information only. Peptides such as BPC-157, MOTS-c, and TB-500 are sold for research purposes only. This article reports on how payment works when purchasing them and does not constitute financial, medical, or legal advice. Consult a licensed physician for personal medical decisions.
This article contains affiliate links to vendor pages; The Peptide Catalog earns a commission on qualifying purchases.
Why peptide payments moved to crypto
Card networks assign research-peptide sellers a high-risk merchant classification. When Visa and Mastercard flag a category as high-risk, the acquiring banks and payment processors that actually move the money face higher scrutiny and liability — and many simply decline to serve the merchant rather than carry the risk.
That pressure intensified through 2025 and 2026. Eli Lilly and Novo Nordisk filed a wave of lawsuits against compounders and telehealth distributors of semaglutide and tirzepatide, and FDA enforcement against research-use-only vendors escalated from warning letters to closures. Processors read those signals and pulled back. Sellers that relied on card rails saw accounts frozen mid-cycle, sometimes with funds held.
The practical result: vendors rotated through processor after processor, and card transactions started declining at high rates for buyers who had done nothing wrong. Cryptocurrency, Zelle, and ACH transfers became the rails that could not be switched off by a third-party bank. Crypto in particular settles directly between buyer and seller, which is why it moved from a fringe option to the one most vendors list first.
Bloomberg's July 20 feature documented that transition across the online peptide market. It is less a trend than an adaptation — the sellers followed the only payment paths that stayed open.
What this means at checkout
Most research-peptide vendors now list cryptocurrency alongside Zelle, ACH, and e-check. The typical crypto options are Bitcoin (BTC) and Ethereum (ETH), and a growing number accept stablecoins such as USDC or USDT — dollar-pegged tokens that avoid the price swings of Bitcoin between placing an order and its confirmation.
Several vendors pair crypto with an outright discount, because it saves them the processing fees and chargeback exposure of cards. EZ Peptides, for example, applies a standing crypto discount of roughly 10 percent at checkout — a pattern documented across our own order records rather than a one-off promo. Discounts and codes shift often, so the live picture by vendor is maintained on the deals page.
Per-milligram pricing by vendor — the number that actually decides value — is listed on each peptide's buyer page: BPC-157, MOTS-c, and TB-500. The payment method changes the total; it does not change which vendor is cheapest per milligram.
